Rapid microbiology tests expedite the determination of a microorganism causing a symptomatic infection and hence help in selection of a method for its elimination. Rapid diagnosis of an infection with accuracy enables patient for early commencement of therapy and implementation of appropriate infection control measures. Such tests also reduce redundancy of un-required diagnostic testing and treatment. Current rapid microbiology tests include various genomic testing methodologies such as nucleic acid hybridization, polymerase chain reaction (PCR) technologies or nucleic acid sequencing. These tests are highly sensitive and specific in nature and provide accurate outcomes.
Rapid microbiology tests market is categorized based on the following applications:
- Clinical applications
- Automated identification & susceptibility systems
- Automated blood culture systems
- Streptococcus infection rapid tests
- Sexually transmitted diseases rapid tests
- Respiratory disease rapid tests
- Gastrointestinal rapid test
- Other automated & rapid microbiological tests
- Non-clinical applications
Globally, North America dominates the rapid microbiology tests market due to large number of market-focused players providing wider range of product portfolio and is followed by Europe. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the rapid microbiology tests market due to an increase in the number of laboratories in these regions and upgradation of existing ones for automation of various instrumentation systems.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2062
One of the major factors driving the growth of rapid microbiology test markets is the growing need for faster diagnosis. Other factors propelling this market include technological advancement, reduced cost, improved patient satisfaction due to elimination of use of antibiotics and other drugs, impending threat of transmission of AIDS and increased potential of bioterrorism tests. Advancements in molecular diagnostic technologies may pose a challenge to the traditional rapid microbiology test market by causing reduction in sales volume.
Some of the key players contributing in rapid microbiology tests market include Abbott Laboratories, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Gen-Probe, Inc., Orasure Technologies, Inc., Remel, Inc., Siemens Healthcare Diagnostics, Inc., Hoffmann-La Roche Ltd, Thermo-Fischer Scientific, Inc., Sysmex Corporation and Quidel Corporation.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453